Starbucks trending lower after issuing guidance Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Genmab (GMAB) up 3% after AbbVie (ABBV) and the company announced that they have signed a broad collaboration agreement to jointly develop and commercialize three of Genmab's early-stage investigational bispecific antibody product candidates and enter into a discovery research collaboration for future differentiated antibody therapeutics for cancer
- Fulcrum Therapeutics (FULC) up 4% after announcing plans to evaluate losmapimod as a potential treatment for patients with COVID-19
- TrueCar (TRUE) up 16% after
B. Riley FBR analyst Lee Krowl upgraded the stock to Buy from Neutral with a $5 price target
UP AFTER EARNINGS -
- FangDD Network (DUO) up 16%
- Lakeland Industries (LAKE) up 38%
DOWN AFTER EARNINGS -
- United Natural Foods (UNFI) down 6%
- Red Robin (RRGB) down 6%
- Cheetah Mobile (CMCM) down 2%
- GameStop (GME) down 5%
ALSO LOWER -
- Starbucks (SBUX) down 2% after issuing Q3, Q4 and full-year guidance
- Scorpio Bulkers (SALT) down 5% after 4.1M share spot secondary priced at $18.46
- Cardiovascular Systems (CSII) down 11% after 3.676M share spot secondary priced at $34.00
Symbols:
GMAB FULC TRUE DUO LAKE UNFI RRGB CMCM GME SBUX SALT CSII Keywords: Fly Intel, Wall Street, Top Stories, Stocks